Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002818094 | SCV003610781 | uncertain significance | Inborn genetic diseases | 2022-10-03 | criteria provided, single submitter | clinical testing | The c.2550C>G (p.D850E) alteration is located in exon 11 (coding exon 11) of the PKD1 gene. This alteration results from a C to G substitution at nucleotide position 2550, causing the aspartic acid (D) at amino acid position 850 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005021702 | SCV005643105 | uncertain significance | Polycystic kidney disease, adult type | 2024-05-13 | criteria provided, single submitter | clinical testing |